Abiopharma

🔍 OKelly Shane M (Director)

Company: STANLEY BLACK & DECKER, INC. (SWK)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 349 shares of Deferred Shares (Derivative)
  Date: 2026-03-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 349.40 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Represents deferred shares acquired pursuant to the Stanley Black & Decker Deferred Compensation Plan for Non-Employee Directors (the "Deferred Compensation Plan") as a result of the deferral of quarterly director fees paid in cash to the reporting person. Each deferred share entitles the holder thereof to receive one share of common stock upon settlement. The deferred shares credited to the reporting person's account under the Deferred Compensation Plan, including any additional deferred shares acquired through dividend reinvestment, will be settled in three approximately equal annual installments of common stock beginning on the January 15 immediately following the date on which the reporting person ceases to be a member of the Board of Directors.